Healthcare · Nov 10, 2026
Effects of Non-Pharmacological Interventions on Theory of Mind in Older Adults: A Systematic Literature Review
By Ferreira DA, Osório FL
Background/Objectives: Aging is associated with declines in processing speed, executive functioning, and Theory of Mind (ToM), which may compromise social functioning. ToM interventions, developed mainly for autism and schizophrenia, have been tested in older adults, but their effects remain unsynthesized. This systematic review synthesized the effects of non-pharmacological interventions on ToM in healthy older adults and in those with neurodegenerative/neurocognitive disorders. Methods: Following PRISMA 2020, PubMed, Web of Science, Embase, Scopus, and PsycINFO were searched from inception to 25 January 2026, without language restrictions. Studies reporting at least one performance-based ToM outcome pre/post intervention were eligible. Two reviewers independently screened studies and extracted data; methodological quality was appraised with the Effective Public Health Practice Project (EPHPP) tool, and findings were synthesized narratively by intervention category. Results: Seventeen studies (19 interventions; n = 762; mean age 69.6 years; 73.6% healthy) were included. Eleven interventions were ToM-targeted and eight non-ToM-targeted. ToM improved in 10 of 11 ToM-targeted interventions (91%) at immediate post-intervention, with predominantly moderate-to-large effects; non-ToM-targeted interventions yielded selective gains, mainly in cognitive rather than affective ToM. Nine studies (53%) had weak methodological quality; follow-up was scarce and short, and 88% of the evidence originated in Europe. Conclusions: ToM-targeted interventions in older adults appear promising, although no single intervention is clearly superior. The diversity of strategies, which operate through partially distinct mechanisms, hinders direct comparison but may broaden applicability across clinical profiles and care settings. Evidence remains limited by methodological weaknesses, predominantly healthy samples with preserved baseline cognition, heterogeneous ToM measures, scarce follow-up, and geographic concentration. Future trials should enroll clinical samples and use standardized ToM outcomes.